Values First Advisors’s DexCom DXCM Stock Holding History

Values First Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32	Closed	-$3.69K	–	215
2023 Q1	$3.69K	Buy	+32	New	+$3.58K	﹤0.01%	240

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Values First Advisors's DXCM Position: Q2 2023 in Review

Values First Advisors sold out of DexCom (DXCM) in Q2 2023, closing a stake of 32 shares — an estimated $3.69K sold.

Values First Advisors first reported a position in DXCM in Q1 2023 and held it in 1 quarter. The position peaked at $3.69K in Q1 2023. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

Values First Advisors reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
Values First Advisors sold 32 DexCom shares in Q2 2023, an estimated $3.69K.
Values First Advisors first reported a position in DexCom in Q1 2023 and held it in 1 quarter.
Values First Advisors's DexCom position peaked at $3.69K in Q1 2023.
954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Values First Advisors's 13F filing for Q2 2023, filed 2 Aug 2023.